EPD560 | Characterization of the microbiome in breast cancer patients diagnosed with COVID-19 | E-poster | Effects of the COVID-19 on key populations |
EPB173 | Characterization of the absorption, metabolism, and excretion of islatravir, an HIV nucleoside reverse transcriptase translocation inhibitor, in humans | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
EPA094 | Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1 infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection | E-poster | SARS-Cov2 vaccines |
EPA003 | Characterization of novel candidate factors impacting HIV life cycle | E-poster | HIV biology (entry, replicative cycle, transcriptional expression and regulation) |
EPA055 | Characterization of Hiv-1 intact and near-full length defective proviral populations during long-term suppression on antiretroviral therapy | E-poster | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
EPD065 | Characteristics of chemsexers in France during the COVID-19 pandemic: results from the ERAS 2021 national online survey | E-poster | Gay men other men who have sex with men |
OAC0303 | Characteristics associated with viral suppression among transgender women with HIV in 7 U.S. cities, NHBS-Trans, 2019-2020 | Oral abstract session with live Q&A | Surveillance of HIV in key populations |
EPC169 | Characteristics associated with PrEP pilot program participation among MSM in the Netherlands | E-poster | Demonstration and pilot projects for prevention (including PrEP, PEP, male circumcision) |
EPC404 | Characteristics and clinical outcomes of patients receiving HIV diagnoses in emergency departments in Philadelphia, 2014-2019 | E-poster | HIV testing to support identification of new cases of people living with HIV |
PESUC23 | Characterising the HIV care cascade in Saskatoon, Saskatchewan, 2018 - 2021 | Poster exhibition | Modelling the impact of service models on the HIV epidemic |